Â¥
10.96
Apr 30
Business Description
Jiangsu Wuzhong Pharmaceutical Development Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000YP4
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.04 | |||||
Debt-to-EBITDA | -132.69 | |||||
Altman Z-Score | 2.32 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.9 | |||||
3-Year EPS without NRI Growth Rate | 15.3 | |||||
3-Year FCF Growth Rate | 14.8 | |||||
3-Year Book Growth Rate | -1.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.14 | |||||
9-Day RSI | 49.08 | |||||
14-Day RSI | 50.32 | |||||
6-1 Month Momentum % | 17.17 | |||||
12-1 Month Momentum % | 41.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 1.22 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 22.86 | |||||
Days Sales Outstanding | 162.07 | |||||
Days Payable | 46.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.37 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.02 | |||||
Operating Margin % | -0.89 | |||||
Net Margin % | -4.08 | |||||
FCF Margin % | -8.48 | |||||
ROE % | -5.28 | |||||
ROA % | -2.25 | |||||
ROIC % | -0.73 | |||||
ROC (Joel Greenblatt) % | -1.61 | |||||
ROCE % | -0.68 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.41 | |||||
PB Ratio | 4.5 | |||||
Price-to-Tangible-Book | 5.15 | |||||
EV-to-EBIT | -582.46 | |||||
EV-to-EBITDA | -582.46 | |||||
EV-to-Revenue | 3.41 | |||||
EV-to-FCF | -40.23 | |||||
Price-to-Projected-FCF | 12.04 | |||||
Price-to-Median-PS-Value | 1.25 | |||||
Price-to-Net-Current-Asset-Value | 23.83 | |||||
Earnings Yield (Greenblatt) % | -0.17 | |||||
FCF Yield % | -2.51 | |||||
Forward Rate of Return (Yacktman) % | -4.78 |